Literature DB >> 12787643

Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers.

Parag Kolhe1, Ekta Misra, Rangaramanujam M Kannan, Sujatha Kannan, Mary Lieh-Lai.   

Abstract

Highly branched, functionalized polymers have potential to act as efficient drug carrier systems. Dendrimers are ideal candidates among model hyperbranched polymers because of their well-defined structure and high density of functional groups. Using ibuprofen as a model drug, we studied the interaction between the drug and Polyamidoamine (PAMAM) dendrimers (generations 3 and 4 with --NH2 functionality) and Perstrop Polyol (generation 5, hyperbranched polyester with --OH functionality). FTIR and NMR studies suggest that ibuprofen predominantly forms a complex with PAMAM dendrimers because of the ionic interaction between the --NH2 end groups and the carboxyl group of ibuprofen. On an average, up to 78 molecules of ibuprofen could be incorporated into one molecule of PAMAM-G4-NH2 with 64 end groups. This complex is stable in deionized water and methanol. The in vitro release of ibuprofen from drug-dendrimer complex is appreciably slower compared to pure ibuprofen. The complexed drug enters A549 cells much more rapidly than pure drug suggesting that dendrimers may be able to carry the complexed drug inside cells efficiently. Hyperbranched Polyol (with 128 --OH end groups) appears to encapsulate approximately 24 drug molecules. Perhaps the lack of strong interactions between the --OH end groups and the drugs prevents complex formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787643     DOI: 10.1016/s0378-5173(03)00225-4

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  51 in total

1.  Dendrimer interactions with hydrophobic fluorescent probes and human serum albumin.

Authors:  D Shcharbin; B Klajnert; V Mazhul; M Bryszewska
Journal:  J Fluoresc       Date:  2005-01       Impact factor: 2.217

Review 2.  Enabling individualized therapy through nanotechnology.

Authors:  Jason H Sakamoto; Anne L van de Ven; Biana Godin; Elvin Blanco; Rita E Serda; Alessandro Grattoni; Arturas Ziemys; Ali Bouamrani; Tony Hu; Shivakumar I Ranganathan; Enrica De Rosa; Jonathan O Martinez; Christine A Smid; Rachel M Buchanan; Sei-Young Lee; Srimeenakshi Srinivasan; Matthew Landry; Anne Meyn; Ennio Tasciotti; Xuewu Liu; Paolo Decuzzi; Mauro Ferrari
Journal:  Pharmacol Res       Date:  2010-01-05       Impact factor: 7.658

3.  Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers.

Authors:  Hannah L Crampton; Eric E Simanek
Journal:  Polym Int       Date:  2007-03-02       Impact factor: 2.990

4.  Prebiotic alternatives to proteins: structure and function of hyperbranched polyesters.

Authors:  Irena Mamajanov; Michael P Callahan; Jason P Dworkin; George D Cody
Journal:  Orig Life Evol Biosph       Date:  2015-05-20       Impact factor: 1.950

Review 5.  Immunosuppressive and anti-inflammatory properties of engineered nanomaterials.

Authors:  A N Ilinskaya; M A Dobrovolskaia
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

6.  Sustained analgesia achieved through esterase-activated morphine prodrugs complexed with PAMAM dendrimer.

Authors:  Brent B Ward; Baohua Huang; Ankur Desai; Xue-Min Cheng; Mark Vartanian; Hong Zong; Xiangyang Shi; Thommey P Thomas; Alina E Kotlyar; Abraham Van Der Spek; Pascale R Leroueil; James R Baker
Journal:  Pharm Res       Date:  2012-09-28       Impact factor: 4.200

7.  Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery.

Authors:  Yunus E Kurtoglu; Raghavendra S Navath; Bing Wang; Sujatha Kannan; Robert Romero; Rangaramanujam M Kannan
Journal:  Biomaterials       Date:  2009-01-25       Impact factor: 12.479

Review 8.  Nanostructured materials for applications in drug delivery and tissue engineering.

Authors:  Michael Goldberg; Robert Langer; Xinqiao Jia
Journal:  J Biomater Sci Polym Ed       Date:  2007       Impact factor: 3.517

9.  Targeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivo.

Authors:  Andrzej Myc; Jolanta Kukowska-Latallo; Peter Cao; Ben Swanson; Julianna Battista; Thomas Dunham; James R Baker
Journal:  Anticancer Drugs       Date:  2010-02       Impact factor: 2.248

Review 10.  Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs.

Authors:  Simi Gunaseelan; Krishnan Gunaseelan; Manjeet Deshmukh; Xiaoping Zhang; Patrick J Sinko
Journal:  Adv Drug Deliv Rev       Date:  2009-11-24       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.